What is the recommended acute and secondary management of a variceal bleed?

Management of Variceal Bleeding

For acute variceal bleeding, immediately start vasoactive drugs (octreotide in the US, terlipressin elsewhere) and antibiotics (ceftriaxone 1g IV daily) before endoscopy, then perform endoscopic band ligation within 12 hours; for secondary prophylaxis, combine nonselective beta-blockers at maximal tolerated dose with endoscopic variceal ligation every 1-2 weeks until obliteration. 1, 2

Acute Management

Immediate Resuscitation (Before Endoscopy)

Start these interventions as soon as variceal bleeding is suspected:

• Hemodynamic stabilization: Maintain hemoglobin at 7-8 g/dL with restrictive transfusion strategy 1, 3
• Vasoactive drugs: Start immediately, continue for 3-5 days 1
  • Octreotide (only option in US): 50 mcg IV bolus, then 50 mcg/hr continuous infusion 2
  • Terlipressin (preferred where available): 2 mg IV every 4 hours for 48 hours, then 1 mg every 4 hours 2, 4
  • Somatostatin: 250 mcg IV bolus, then 250-500 mcg/hr infusion 2
• Antibiotics: Ceftriaxone 1g IV daily for up to 7 days 1, 2, 3
  • This is superior to norfloxacin in advanced cirrhosis and settings with quinolone resistance 2
  • Reduces infection risk, rebleeding, and mortality 1
• Erythromycin: 250 mg IV given 30-120 minutes before endoscopy improves visualization 3

Endoscopic Therapy

Perform upper endoscopy within 12 hours once hemodynamically stable 1, 5, 3

• Endoscopic variceal ligation (EVL) is the treatment of choice for esophageal varices 1, 3
• Sclerotherapy only if EVL technically not feasible 1
• For gastric varices (GOV2, IGV1): cyanoacrylate injection is preferred 1, 3

Risk Stratification for Early TIPS

Identify high-risk patients who need preemptive TIPS within 72 hours (ideally <24 hours): 2, 3

• Child-Pugh C score 10-13, OR
• Child-Pugh B with active bleeding at endoscopy despite vasoactive drugs, OR
• HVPG >20 mmHg (if measured)

Early TIPS with covered stents in these high-risk patients significantly reduces treatment failure and mortality 2, 4

Salvage Therapy for Treatment Failure

If bleeding cannot be controlled or recurs early (10-20% of cases):

• TIPS is the rescue treatment of choice 1, 5
• Balloon tamponade as temporary bridge (maximum 24 hours) to definitive therapy 1, 5
• Self-expanding esophageal metal stents are an alternative to balloon tamponade 5

Secondary Prophylaxis (Preventing Rebleeding)

All patients surviving an acute variceal bleed require secondary prophylaxis 1

Combination Therapy (Best Option)

Nonselective beta-blockers PLUS endoscopic variceal ligation is the optimal strategy 1, 3

Beta-blocker regimen:

• Propranolol or nadolol titrated to maximal tolerated dose 1
• Carvedilol may be preferred (better portal pressure reduction) 3
• Goal: reduce heart rate by 25% or to 55-60 bpm

EVL schedule:

• Repeat every 1-2 weeks until variceal obliteration 1
• First surveillance endoscopy 1-3 months after obliteration 1
• Then every 6-12 months to check for recurrence 1

TIPS for Refractory Cases

Consider TIPS in Child-Pugh A or B patients with recurrent bleeding despite combination therapy 1

• Covered stents have lower occlusion rates and less encephalopathy than bare stents 1
• TIPS reduces rebleeding but increases encephalopathy risk and does not improve survival compared to endoscopic therapy in unselected patients 1, 6
• Surgical shunt (distal splenorenal) can be considered in Child-Pugh A patients at centers with expertise 1

Critical Pitfalls to Avoid

Do NOT use sclerotherapy for secondary prophylaxis - EVL is superior with fewer complications 1

Do NOT combine EVL with sclerotherapy - increases esophageal strictures without benefit 1

Do NOT use tranexamic acid - no benefit demonstrated in variceal bleeding 7

Do NOT delay vasoactive drugs - start before endoscopy, not after 1, 2

Do NOT use TIPS as first-line secondary prophylaxis - reserve for failures of medical/endoscopic therapy 1

Special Considerations

For gastric varices (fundal varices GOV2/IGV1): cyanoacrylate injection is more effective than EVL or sclerotherapy 1, 3

For transplant candidates: refer to transplant center as variceal bleeding may affect listing priority 1

The evidence strongly supports this algorithmic approach, with multiple high-quality guidelines from Hepatology [1-1,2] and recent ESGE guidelines 3 providing consistent Class I, Level A recommendations for the core interventions.